Hata, Aaron N
Niederst, Matthew J
Archibald, Hannah L
Gomez-Caraballo, Maria
Siddiqui, Faria M
Mulvey, Hillary E
Maruvka, Yosef E
Ji, Fei
Bhang, Hyo-eun C http://orcid.org/0000-0003-1892-7093
Krishnamurthy Radhakrishna, Viveksagar
Siravegna, Giulia
Hu, Haichuan
Raoof, Sana
Lockerman, Elizabeth
Kalsy, Anuj
Lee, Dana
Keating, Celina L
Ruddy, David A
Damon, Leah J
Crystal, Adam S
Costa, Carlotta
Piotrowska, Zofia
Bardelli, Alberto
Iafrate, Anthony J
Sadreyev, Ruslan I
Stegmeier, Frank
Getz, Gad
Sequist, Lecia V
Faber, Anthony C
Engelman, Jeffrey A
Article History
Received: 4 August 2015
Accepted: 28 December 2015
First Online: 1 February 2016
Competing interests
: J.A.E. is a consultant for Novartis, Sanofi, Genentech, Clovis and Astra Zeneca; owns equity in Gatekeeper Pharmaceuticals, which has interest in EGFR<sup>T790M</sup> inhibitors; and has research agreements with Novartis and AstraZeneca. A.N.H. has provided consulting services for Amgen. M.J.N. has provided consulting services for Boehringer Ingelheim Pharmaceuticals. Z.P. has provided consulting services for Clovis Oncology and Boehringer Ingelheim Pharmaceuticals. L.V.S. has provided uncompensated consulting services to Clovis Oncology, AstraZeneca, Novartis, Boehringer Ingelheim Pharmaceuticals, Merrimack Pharmaceuticals, Genentech and Taiho Pharmaceuticals. H.C.B., V.K.R., C.L.K., D.A.R., A.S.C. and F.S. are employees of Novartis, Inc., as noted in the affiliations.